Interactions on record — worth a quick check against your medications. Based on 3 of 5 ingredients. Check your meds →
Dietary supplement

Relevia UC-II Ingredients & Drug Interactions

by NewtonEverett

Capsule Category: Other Combinations
Most serious interaction: Moderate
The interaction bottom line Most serious interaction: Moderate

Relevia UC-II is a dietary supplement by NewtonEverett with 5 active ingredients. Its ingredients are commonly taken for skin hydration and aging, joint comfort and osteoarthritis, dry eyes.Based on those ingredients, 62 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Potassium Chloride. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of Relevia UC-II by NewtonEverett

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Partial disclosure
Ingredient Transparency · database check
Partial

Most active ingredients list an amount, but at least one is hidden in a blend or missing.

Why this rating?
  • The label discloses an exact amount for 3 of its 5 active ingredients.
  • “UC-II standardized Cartilage Blend” is a proprietary blend — the label gives one combined amount (40 mg) without saying how much of each component you get.

Relevia UC-II contains five active ingredients. Potassium chloride is a mineral supplement form of potassium.

Hyaluronic acid is a naturally occurring compound in joints and connective tissue. Boron glycinate is boron bound to the amino acid glycine.

The product also includes cartilage and a standardized cartilage blend (UC-II), which are forms of collagen thought to support joint structure, plus a total collagen component. The capsule itself and the rice flour, magnesium stearate, and silica are inactive ingredients that help hold the formula together.

Does it work?

Strong evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Strong

Clinical evidence supports at least one of this product's ingredients for its stated purpose.

Why this rating?
  • The label markets this product for: joint, cartilage and bone health.
  • We looked for evidence on: Osteoarthritis, Osteoporosis, Boron deficiency, Cartilage degradation, Joint mobility, Connective tissue support.
  • The strongest evidence on file: Boron is rated "Likely Effective" for Boron deficiency (Natural Medicines).
  • Also on file: Boron is rated "Insufficient Reliable Evidence To Rate" for Osteoporosis, Osteoarthritis.
  • Also on file: Hyaluronic Acid is rated "Insufficient Reliable Evidence To Rate" for Osteoarthritis.

Hyaluronic acid is possibly effective for dry eye and venous leg ulcers (slow-healing leg wounds), but there isn't enough evidence to rate it for aging skin, hay fever, or sexual dysfunction. Boron glycinate is likely effective for boron deficiency and possibly effective for vaginal yeast infections and radiation-related skin damage, though it appears possibly ineffective for athletic performance.

The effectiveness data we hold doesn't cover potassium supplementation, cartilage, or collagen for any specific use, so we can't speak to what this product may do for joint health or any other purpose.

The evidence, ingredient by ingredient Hyaluronic Acid Boron Potassium

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 3 of the 3 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 3 of 3.
  • General safety write-ups exist for 3 of 3.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Potassium is generally well tolerated by mouth, but excess levels can cause serious problems—especially in people with kidney disease. Common side effects are abdominal pain, nausea, diarrhea, and bloating; in rare cases, high potassium can cause irregular heartbeat, heart block, low blood pressure, and confusion.

Boron is generally safe in small dietary amounts and low doses, but high doses can be toxic. Hyaluronic acid appears well tolerated overall, though long-term safety of oral supplements isn't fully studied.

For pregnancy and breastfeeding: potassium from food is fine, but the data advises against using potassium supplements during pregnancy and breastfeeding without medical guidance. Boron supplements are advised against in pregnancy and breastfeeding due to potential fetal harm and insufficient safety data.

We have no pregnancy/breastfeeding information on file for hyaluronic acid.

Side effects, ingredient by ingredient Hyaluronic Acid Boron Potassium

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 1 of the 3 matched ingredients can interact with medications — Potassium.
  • The most serious interaction on file is rated Moderate.
  • For scale: 62 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Check with your pharmacist if you take potassium-sparing diuretics, ACE inhibitors, or angiotensin receptor blockers (ARBs)—these all carry a Moderate risk of dangerously high potassium levels when combined with this product. People with kidney disease are at extra risk.

No interactions are documented for the hyaluronic acid, boron, or cartilage components with any medications we could check.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glancePartially disclosed formula with clinical evidence supporting its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.

This product is mainly a potassium and joint-support formula. If you take blood pressure medications—especially diuretics, ACE inhibitors, or ARBs—you need to check with your pharmacist before starting it, because potassium can interact dangerously with those drugs.

Anyone with kidney disease should also talk to their doctor first. If you're pregnant or breastfeeding, discuss this with your doctor before taking it.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 3 of 5 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Jan 25, 2018.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Relevia UC-II, straight from the product label.

Brand NewtonEverett
Barcode (UPC) 818423028880
Net contents 30 Capsule(s)
Market status On market
Date entered into DSLD Jan 25, 2018
DSLD ID 82648
Product type Other Combinations
Supplement form Capsule
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Relevia UC-II by NewtonEverett, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container
30
UPC/BARCODE
818423028880
IngredientAmount% DV
Potassium Chloride0 NP--
Hyaluronic Acid3.3 mg--
Boron Glycinate5 mg--
Cartilage0 NP--
UC-II standardized Cartilage Blend40 mg--
total Collagen10 mg--

Other ingredients: HPMC Vegetable Capsule, Rice Flour, Vegetable Magnesium Stearate, Silicon Dioxide

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formula

Superflex-UC-II with undenatured type II collagen provides convenient & effective joint, cartilage and bone health.

1) UC-II is derived from protein found in natural cartilage. It works to promote a healthy immune response for improved joint and cartilage health 2) Hyaluronic acid provides cushioning and lubrication for joint comfort 3) Boron improves absorption of calcium, magnesium and vitamin D for strong, healthy bones

UC-II Collagen 40mg Boron 5mg Hyaluronic Acid 3.3mg

Suggested/Recommended/Usage/Directions

Just one small capsule daily contains three advanced ingredients for increased comfort and mobility to support your active lifestyle.

Just 1 small capsule per day

Suggested Use: As a dietary supplement, take one (1) capsule daily.

Brand IP Statement(s)

UC-II is a registered trademark of InterHealth N.I. UC-II brand collagen with undenatured type II collagen (U.S. Patents 7,846,487, 7,083,820 and EP0 Patent EP1435906B1; Canadian patent CA 2459981C; and Japanese Patent JP 4800574B2).

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

General Statements

Joint, cartilage & bone Advanced action

Flexibility Comfort Mobility

Actual size

FDA Statement of Identity

Dietary Supplement

Precautions

Warning: Consult a physician before using if pregnant, nursing or on medication.

Do not use if safety seal is broken. Do not exceed suggested daily intake.

Keep out of reach of children.

Storage

Store in a cool, dry place.

General

#12476 - K16

See for yourself

Relevia UC-II by NewtonEverett label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in Relevia UC-II by NewtonEverett

These are the 5 active ingredients this product is made of. Select any to open its full monograph.

Serving size1 Capsule(s) Dosage formCapsule Servings per container30 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Hyaluronic Acid

No known
interactions
3.3 mg per serving

Hyaluronic acid is a natural substance in the body that helps hold water in the skin, joints, and eyes. Oral and topical products are popular for skin...

Hyaluronic Acid monograph & interactions

Boron Glycinate

No known
interactions
5 mg per serving

Boron is a trace mineral found in many plant foods and sold as a supplement, mainly promoted for bone, joint, and hormone health. The human evidence f...

Boron Glycinate monograph & interactions

UC-II standardized Cartilage Blend

40 mg per serving

Other (inactive) ingredients: HPMC Vegetable Capsule, Rice Flour, Vegetable Magnesium Stearate, Silicon Dioxide. These complete the product’s ingredient list but are not active constituents.

Interaction report

Relevia UC-II by NewtonEverett Drug Interactions

Want to check YOUR meds against Relevia UC-II?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
62Drugs
62 Moderate

Ingredients driving the most interactions

Each ingredient & the kinds of drugs it affects

For each ingredient in Relevia UC-II with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.

Potassium Chloride3 drug types · 62 drugs

Ace Inhibitors (Aceis)

Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
ACEIs block the actions of the renin-angiotensin-aldosterone system and reduce potassium excretion. Concomitant use of these drugs with potassium supplements increases the risk of hyperkalemia. However, concomitant use of these drugs with moderate dietary potassium intake (about 3775-5200 mg daily) does not increase serum potassium levels.

Likelihood Likely Evidence C
Angiotensin Receptor Blockers (Arbs)

Using ARBs with high doses of potassium increases the risk of hyperkalemia.
ARBs block the actions of the renin-angiotensin-aldosterone system and reduce potassium excretion. Concomitant use of these drugs with potassium supplements increases the risk of hyperkalemia. However, concomitant use of these drugs with moderate dietary potassium intake (about 3775-5200 mg daily) does not increase serum potassium levels.

Likelihood Likely Evidence C
Potassium-Sparing Diuretics

Concomitant use increases the risk of hyperkalemia.
Using potassium-sparing diuretics with potassium supplements increases the risk of hyperkalemia.

Likelihood Likely Evidence C
The maker

Brand information

Manufacturer and brand details for Relevia UC-II, from the product label.

NewtonEverett

See all NewtonEverett products
Name
Newton-Everett Biotech
City
Scottsdale
State
AZ
ZipCode
85255
Phone Number
866.593.3424
Web Address
www.newton-everett.com
Pharmacist Counseling Corner

Relevia UC-II by NewtonEverett: Common Questions

Does Relevia UC-II by NewtonEverett interact with any medications?
Yes. Based on its ingredients, Relevia UC-II has a known interaction with 62 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Relevia UC-II contains 5 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
What is UC-II and why is it in this product?
UC-II is a standardized cartilage blend—a form of collagen thought to support joint structure and health. It's one of the product's main active ingredients, combined with hyaluronic acid and boron to create a joint-support formula.
Why does this product have potassium in it?
Potassium chloride is included as a mineral supplement. Potassium is essential for heart and muscle function, though the product's facts don't specify what health goal the potassium is meant to support here.
Can I take this if I'm pregnant or breastfeeding?
The data advises against using potassium supplements and boron supplements during pregnancy and breastfeeding without medical guidance. Dietary potassium and boron from food are fine. Talk to your doctor or pharmacist about whether this product is right for you personally.
What are the most common side effects?
Potassium can cause abdominal pain, nausea, diarrhea, belching, and gas. Boron at low doses is generally well tolerated, and hyaluronic acid appears safe for most adults. Serious effects from potassium are rare but can include irregular heartbeat and heart block if levels get too high.
Is this safe for people with kidney disease?
No—the safety data cautions that potassium supplements can cause dangerously high blood levels in people with kidney disease. Check with your doctor before taking this product if you have any kidney problems.
Does this product have any fillers?
Yes, it contains inactive ingredients: an HPMC vegetable capsule, rice flour, vegetable magnesium stearate, and silicon dioxide. These are standard capsule and tablet materials.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Relevia UC-II is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Relevia UC-II label
Sources

Sources & How We Checked

Relevia UC-II's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 22 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Potassium 12 references
  1. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  2. Gennaro A. Remington: The Science and Practice of Pharmacy. 19th ed. Lippincott: Williams & Wilkins, 1996.
  3. Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997;277:1624-32. PubMed
  4. Phillips, C. O., Kashani, A., Ko, D. K., Francis, G., and Krumholz, H. M. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from ra DOI
  5. Altieri, P. I., Herrero, C., Suero, R., and Ortiz, A. Bleeding duodenal ulcer in a patient taking slow-releasing potassium tablets. Bol.Asoc.Med P.R. 1977;69(8):276.
  6. Raf, L. E. Enteric-coated potassium chloride tablets and ulcer of the small intestine. Acta Chir Scand Suppl 1967;(374):1-87.
  7. Potassium chloride oral solution [package insert]. Allentown, PA: Lehigh Valley Technologies, Inc.; 2014.
  8. Potassium chloride injection [package insert]. Lake Forest, IL: Hospira Inc.; 2009.
  9. Patel RB, Tannenbaum S, Viana-Tejedor A, et al. Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36. Eur Heart J Acute Cardiovasc Care 2017 Feb;6(1):1 PubMed
  10. Malta D, Arcand J, Ravindran A, Floras V, Allard JP, Newton GE. Adequate intake of potassium does not cause hyperkalemia in hypertensive individuals taking medications that antagonize the renin angiotensin aldosterone system. Am J Clin Nutr 2016 Oct;104(4 PubMed
  11. Keskin M, Kaya A, Tatlisu MA, et al. The effect of serum potassium level on in-hospital and long-term mortality in ST elevation myocardial infarction. Int J cardiol. 2016 Oct 15;221:505-10.
  12. Stallings VA, Harrison M, Oria M; Committee to Review the Dietary Reference Intakes for Sodium and Potassium, Food and Nutrition Board, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine. Washington (DC): National Acad

See these in context on the Potassium monograph →

Hyaluronic Acid 4 references
  1. Park Y, Song JS, Choi CY, Yoon KC, Lee HK, Kim HS. A randomized multicenter study comparing 0.1%, 0.15%, and 0.3% sodium hyaluronate with 0.05% cyclosporine in the treatment of dry eye. J Ocul Pharmacol Ther. 2017;33(2):66-72. PubMed
  2. U.S. Food and Drug Administration. Do Not Use Needle-Free Devices for Injection of Dermal Fillers - FDA Safety Communication. October 8, 2021. Available at: https://www.fda.gov/medical-devices/safety-communications/do-not-use-needle-free-devices-injection
  3. Disphanurat W, Srisantithum B. Efficacy and safety of 0.15% isobutylamido thiazolyl resorcinol combined with hyaluronic acid vs 0.15% isobutylamido thiazolyl resorcinol or hyaluronic acid alone in melasma treatment: A randomized evaluator-blind trial. J C PubMed
  4. Humbert P, Mikosinki J, Benchikhi H, Allaert FA. Efficacy and safety of a gauze pad containing hyaluronic acid in treatment of leg ulcers of venous or mixed origin: a double-blind, randomised, controlled trial. Int Wound J 2013;10(2):159-66. PubMed

See these in context on the Hyaluronic Acid monograph →

Boron 6 references
  1. Ellenhorn MJ, et al. Ellenhorn's Medical Toxicology: Diagnoses and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams & Wilkins, 1997.
  2. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002.
  3. Thai L, Hart LL. Boric acid vaginal suppositories. Ann Pharmacother 1993;27:1355-7.
  4. Acs N, Banhidy F, Puho E, Czeizel AE. Teratogenic effects of vaginal boric acid treatment during pregnancy. Int J Gynaecol Obstet 2006;93:55-6. PubMed
  5. Garabrant, D. H., Bernstein, L., Peters, J. M., and Smith, T. J. Respiratory and eye irritation from boron oxide and boric acid dusts. J Occup Med 1984;26(8):584-586. PubMed
  6. Hjelm C, Harari F, Vahter M. Pre- and postnatal environmental boron exposure and infant growth: results from a mother-child cohort in northern Argentina. Environ Res 2019;171:60-8. PubMed

See these in context on the Boron monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring